Clínica Universidad de Navarra (CUN)
Centro clínico de la Universidad de Navarra
Lund University
Lund, SueciaPublicaciones en colaboración con investigadores/as de Lund University (22)
2021
-
CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation
Nature Communications, Vol. 12, Núm. 1
2020
-
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
The Lancet Neurology, Vol. 19, Núm. 11, pp. 951-962
-
Longitudinal functional connectivity changes related to dopaminergic decline in Parkinson's disease
NeuroImage: Clinical, Vol. 28
2019
-
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology, Vol. 30, Núm. 8, pp. 1194-1220
-
Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition
JCO Precision Oncology
2018
-
11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study
Movement Disorders, Vol. 33, Núm. 1, pp. 117-127
-
Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Annals of Oncology, Vol. 29, Núm. 2, pp. 405-417
-
Complement C4d-specific antibodies for the diagnosis of lung cancer
Oncotarget, Vol. 9, Núm. 5, pp. 6346-6355
-
How do experienced professors teach palliative medicine in european universities? a cross-case analysis of eight undergraduate educational programs
Journal of Palliative Medicine, Vol. 21, Núm. 11, pp. 1621-1626
2017
-
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility
European Journal of Neurology, Vol. 24, Núm. 2, pp. 357-365
-
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study
Leukemia, Vol. 31, Núm. 11, pp. 2443-2448
-
Second primary malignancies in multiple myeloma: An overview and IMWG consensus
Annals of Oncology, Vol. 28, Núm. 2, pp. 228-245
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2016
-
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
Science Translational Medicine, Vol. 8, Núm. 341
-
Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis
Stroke, Vol. 47, Núm. 5, pp. 1312-1318
2014
-
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
American Journal of Hematology, Vol. 89, Núm. 4, pp. 355-362
-
Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels
BMC Infectious Diseases, Vol. 14, Núm. 1
2013
-
Suicidal ideation in a European Huntington's disease population
Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258
2012
-
Mortality after surgery in Europe: A 7 day cohort study
The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065
2011
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine